nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—TP53—salivary gland cancer	0.747	1	CbGaD
Acetylsalicylic acid—TP53—neck—salivary gland cancer	0.00373	0.0552	CbGeAlD
Acetylsalicylic acid—NFKBIA—neck—salivary gland cancer	0.00367	0.0543	CbGeAlD
Acetylsalicylic acid—HSPA5—neck—salivary gland cancer	0.00359	0.0532	CbGeAlD
Acetylsalicylic acid—NFKBIA—parotid gland—salivary gland cancer	0.00299	0.0442	CbGeAlD
Acetylsalicylic acid—HSPA5—parotid gland—salivary gland cancer	0.00293	0.0433	CbGeAlD
Acetylsalicylic acid—TP53—saliva-secreting gland—salivary gland cancer	0.00291	0.0431	CbGeAlD
Acetylsalicylic acid—NFKBIA—saliva-secreting gland—salivary gland cancer	0.00286	0.0424	CbGeAlD
Acetylsalicylic acid—HSPA5—saliva-secreting gland—salivary gland cancer	0.0028	0.0415	CbGeAlD
Acetylsalicylic acid—TP53—connective tissue—salivary gland cancer	0.00267	0.0396	CbGeAlD
Acetylsalicylic acid—NFKBIA—connective tissue—salivary gland cancer	0.00263	0.0389	CbGeAlD
Acetylsalicylic acid—HSPA5—connective tissue—salivary gland cancer	0.00258	0.0381	CbGeAlD
Acetylsalicylic acid—TP53—epithelium—salivary gland cancer	0.00254	0.0376	CbGeAlD
Acetylsalicylic acid—NFKBIA—epithelium—salivary gland cancer	0.0025	0.0369	CbGeAlD
Acetylsalicylic acid—RPS6KA3—parotid gland—salivary gland cancer	0.00249	0.0369	CbGeAlD
Acetylsalicylic acid—HSPA5—epithelium—salivary gland cancer	0.00245	0.0362	CbGeAlD
Acetylsalicylic acid—RPS6KA3—saliva-secreting gland—salivary gland cancer	0.00239	0.0353	CbGeAlD
Acetylsalicylic acid—RPS6KA3—connective tissue—salivary gland cancer	0.00219	0.0325	CbGeAlD
Acetylsalicylic acid—TP53—lymphoid tissue—salivary gland cancer	0.00196	0.0289	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymphoid tissue—salivary gland cancer	0.00192	0.0285	CbGeAlD
Acetylsalicylic acid—HSPA5—lymphoid tissue—salivary gland cancer	0.00188	0.0279	CbGeAlD
Acetylsalicylic acid—IKBKB—connective tissue—salivary gland cancer	0.00162	0.024	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lymphoid tissue—salivary gland cancer	0.0016	0.0237	CbGeAlD
Acetylsalicylic acid—IKBKB—lymphoid tissue—salivary gland cancer	0.00118	0.0175	CbGeAlD
Acetylsalicylic acid—TP53—lymph node—salivary gland cancer	0.0011	0.0163	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymph node—salivary gland cancer	0.00109	0.0161	CbGeAlD
Acetylsalicylic acid—HSPA5—lymph node—salivary gland cancer	0.00106	0.0157	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lymph node—salivary gland cancer	0.000905	0.0134	CbGeAlD
Acetylsalicylic acid—EDNRA—lymph node—salivary gland cancer	0.000736	0.0109	CbGeAlD
Acetylsalicylic acid—IKBKB—lymph node—salivary gland cancer	0.000668	0.00989	CbGeAlD
Acetylsalicylic acid—PTGS1—connective tissue—salivary gland cancer	0.000539	0.00797	CbGeAlD
Acetylsalicylic acid—PTGS2—connective tissue—salivary gland cancer	0.000515	0.00762	CbGeAlD
Acetylsalicylic acid—PTGS1—epithelium—salivary gland cancer	0.000512	0.00757	CbGeAlD
Acetylsalicylic acid—PTGS2—epithelium—salivary gland cancer	0.000489	0.00724	CbGeAlD
Acetylsalicylic acid—ALB—lymph node—salivary gland cancer	0.00039	0.00577	CbGeAlD
Acetylsalicylic acid—PTGS2—lymphoid tissue—salivary gland cancer	0.000377	0.00557	CbGeAlD
Acetylsalicylic acid—ABCB1—epithelium—salivary gland cancer	0.000303	0.00448	CbGeAlD
Acetylsalicylic acid—ABCB1—lymphoid tissue—salivary gland cancer	0.000233	0.00345	CbGeAlD
Acetylsalicylic acid—PTGS1—lymph node—salivary gland cancer	0.000222	0.00329	CbGeAlD
Acetylsalicylic acid—PTGS2—lymph node—salivary gland cancer	0.000213	0.00314	CbGeAlD
Acetylsalicylic acid—ABCB1—lymph node—salivary gland cancer	0.000131	0.00194	CbGeAlD
Acetylsalicylic acid—PTGS1—Metabolism—AQP1—salivary gland cancer	2.28e-05	0.000123	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—PIK3CA—salivary gland cancer	2.27e-05	0.000123	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—salivary gland cancer	2.27e-05	0.000123	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—MARCKS—salivary gland cancer	2.23e-05	0.00012	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ISYNA1—salivary gland cancer	2.22e-05	0.00012	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CREBBP—salivary gland cancer	2.22e-05	0.00012	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	2.22e-05	0.00012	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—MARCKS—salivary gland cancer	2.21e-05	0.00012	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—NOTCH1—salivary gland cancer	2.21e-05	0.000119	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CDH1—salivary gland cancer	2.2e-05	0.000119	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—FGFR4—salivary gland cancer	2.19e-05	0.000118	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—HRAS—salivary gland cancer	2.18e-05	0.000118	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—PIK3CA—salivary gland cancer	2.18e-05	0.000118	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	2.18e-05	0.000117	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—DTX4—salivary gland cancer	2.16e-05	0.000117	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MAP2K2—salivary gland cancer	2.16e-05	0.000117	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—FBXW7—salivary gland cancer	2.16e-05	0.000116	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TP53—salivary gland cancer	2.15e-05	0.000116	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—PIK3CA—salivary gland cancer	2.15e-05	0.000116	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	2.14e-05	0.000116	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MAP2K2—salivary gland cancer	2.13e-05	0.000115	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	2.12e-05	0.000115	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—HRAS—salivary gland cancer	2.1e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PHGDH—salivary gland cancer	2.07e-05	0.000112	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PYGB—salivary gland cancer	2.07e-05	0.000112	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—PIK3CA—salivary gland cancer	2.06e-05	0.000111	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PYGB—salivary gland cancer	2.06e-05	0.000111	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—PTEN—salivary gland cancer	2.04e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	2.04e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—HRAS—salivary gland cancer	2.01e-05	0.000109	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—HRAS—salivary gland cancer	2.01e-05	0.000109	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CREBBP—salivary gland cancer	2e-05	0.000108	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ST3GAL4—salivary gland cancer	2e-05	0.000108	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—MARCKS—salivary gland cancer	1.99e-05	0.000107	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—HRAS—salivary gland cancer	1.99e-05	0.000107	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—EP300—salivary gland cancer	1.95e-05	0.000105	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—MARCKS—salivary gland cancer	1.94e-05	0.000105	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MAP2K2—salivary gland cancer	1.93e-05	0.000104	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MAP2K2—salivary gland cancer	1.93e-05	0.000104	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—PIK3CA—salivary gland cancer	1.92e-05	0.000104	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FGF16—salivary gland cancer	1.92e-05	0.000104	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—HRAS—salivary gland cancer	1.91e-05	0.000103	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CREBBP—salivary gland cancer	1.89e-05	0.000102	CbGpPWpGaD
Acetylsalicylic acid—SLC22A6—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.85e-05	0.0001	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PYGB—salivary gland cancer	1.85e-05	9.98e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—FOXO3—salivary gland cancer	1.82e-05	9.82e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—AQP1—salivary gland cancer	1.81e-05	9.79e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—MARCKS—salivary gland cancer	1.81e-05	9.78e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—NUP62—salivary gland cancer	1.81e-05	9.78e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CDH1—salivary gland cancer	1.81e-05	9.75e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PYGB—salivary gland cancer	1.8e-05	9.74e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—VCAN—salivary gland cancer	1.8e-05	9.7e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FGF16—salivary gland cancer	1.79e-05	9.67e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—HRAS—salivary gland cancer	1.78e-05	9.59e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—PTEN—salivary gland cancer	1.77e-05	9.57e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—NOTCH1—salivary gland cancer	1.77e-05	9.56e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—NOTCH1—salivary gland cancer	1.75e-05	9.45e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NUP62—salivary gland cancer	1.72e-05	9.27e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—PTEN—salivary gland cancer	1.71e-05	9.24e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—VCAN—salivary gland cancer	1.7e-05	9.19e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—PIK3CA—salivary gland cancer	1.7e-05	9.19e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—EP300—salivary gland cancer	1.69e-05	9.13e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PHGDH—salivary gland cancer	1.69e-05	9.11e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PYGB—salivary gland cancer	1.68e-05	9.1e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PHGDH—salivary gland cancer	1.68e-05	9.06e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—PIK3CA—salivary gland cancer	1.67e-05	9.04e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MAML2—salivary gland cancer	1.67e-05	9e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—EP300—salivary gland cancer	1.63e-05	8.82e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ST3GAL4—salivary gland cancer	1.62e-05	8.77e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ST3GAL4—salivary gland cancer	1.61e-05	8.72e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CREBBP—salivary gland cancer	1.6e-05	8.67e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CREBBP—salivary gland cancer	1.59e-05	8.57e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—PTEN—salivary gland cancer	1.58e-05	8.56e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NOTCH1—salivary gland cancer	1.58e-05	8.54e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NOTCH1—salivary gland cancer	1.58e-05	8.54e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	1.58e-05	8.51e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—HRAS—salivary gland cancer	1.57e-05	8.5e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	1.57e-05	8.49e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MAML2—salivary gland cancer	1.55e-05	8.4e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—HRAS—salivary gland cancer	1.55e-05	8.36e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	1.52e-05	8.19e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—EP300—salivary gland cancer	1.51e-05	8.16e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	1.51e-05	8.15e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PHGDH—salivary gland cancer	1.51e-05	8.13e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—MAP2K2—salivary gland cancer	1.49e-05	8.02e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CCND1—salivary gland cancer	1.48e-05	8.01e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AQP1—salivary gland cancer	1.47e-05	7.96e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PHGDH—salivary gland cancer	1.47e-05	7.94e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AQP1—salivary gland cancer	1.47e-05	7.92e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	1.46e-05	7.89e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ST3GAL4—salivary gland cancer	1.45e-05	7.83e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	1.45e-05	7.81e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—PIK3CA—salivary gland cancer	1.44e-05	7.79e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—NUP62—salivary gland cancer	1.44e-05	7.76e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CREBBP—salivary gland cancer	1.43e-05	7.75e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CREBBP—salivary gland cancer	1.43e-05	7.75e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—PTEN—salivary gland cancer	1.43e-05	7.73e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—VCAN—salivary gland cancer	1.43e-05	7.7e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—JAG1—salivary gland cancer	1.42e-05	7.69e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FGFR4—salivary gland cancer	1.42e-05	7.65e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	1.41e-05	7.64e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FBXW7—salivary gland cancer	1.39e-05	7.53e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PHGDH—salivary gland cancer	1.37e-05	7.42e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—EP300—salivary gland cancer	1.36e-05	7.37e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—PTEN—salivary gland cancer	1.35e-05	7.31e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—PIK3CA—salivary gland cancer	1.35e-05	7.28e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—HRAS—salivary gland cancer	1.33e-05	7.2e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—JAG1—salivary gland cancer	1.33e-05	7.17e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FGFR4—salivary gland cancer	1.32e-05	7.14e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ST3GAL4—salivary gland cancer	1.32e-05	7.14e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AQP1—salivary gland cancer	1.32e-05	7.11e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FBXW7—salivary gland cancer	1.3e-05	7.02e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—PTEN—salivary gland cancer	1.3e-05	7.02e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—EP300—salivary gland cancer	1.29e-05	6.97e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AQP1—salivary gland cancer	1.28e-05	6.94e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	1.25e-05	6.76e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—PIK3CA—salivary gland cancer	1.25e-05	6.75e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—PIK3CA—salivary gland cancer	1.22e-05	6.61e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—PIK3CA—salivary gland cancer	1.22e-05	6.61e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—PIK3CA—salivary gland cancer	1.21e-05	6.52e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AQP1—salivary gland cancer	1.2e-05	6.48e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CCND1—salivary gland cancer	1.19e-05	6.41e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FOXO3—salivary gland cancer	1.18e-05	6.35e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CCND1—salivary gland cancer	1.17e-05	6.34e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—NUP62—salivary gland cancer	1.17e-05	6.32e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—NUP62—salivary gland cancer	1.16e-05	6.28e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—VCAN—salivary gland cancer	1.16e-05	6.27e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HRAS—salivary gland cancer	1.16e-05	6.25e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—VCAN—salivary gland cancer	1.15e-05	6.23e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—PTEN—salivary gland cancer	1.15e-05	6.19e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—PTEN—salivary gland cancer	1.13e-05	6.12e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—HRAS—salivary gland cancer	1.13e-05	6.11e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—HRAS—salivary gland cancer	1.13e-05	6.11e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	1.13e-05	6.08e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—PIK3CA—salivary gland cancer	1.12e-05	6.04e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—CREBBP—salivary gland cancer	1.11e-05	6.01e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CREBBP—salivary gland cancer	1.1e-05	5.96e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FOXO3—salivary gland cancer	1.1e-05	5.93e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CDH1—salivary gland cancer	1.1e-05	5.91e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—EP300—salivary gland cancer	1.09e-05	5.9e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	1.09e-05	5.87e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—EP300—salivary gland cancer	1.08e-05	5.83e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	1.07e-05	5.8e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	1.07e-05	5.78e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CCND1—salivary gland cancer	1.06e-05	5.73e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CCND1—salivary gland cancer	1.06e-05	5.73e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NUP62—salivary gland cancer	1.04e-05	5.64e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—VCAN—salivary gland cancer	1.04e-05	5.59e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	1.04e-05	5.59e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HRAS—salivary gland cancer	1.03e-05	5.58e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PTEN—salivary gland cancer	1.02e-05	5.53e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PTEN—salivary gland cancer	1.02e-05	5.53e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NUP62—salivary gland cancer	1.02e-05	5.5e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	1.02e-05	5.5e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	1.01e-05	5.47e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—VCAN—salivary gland cancer	1.01e-05	5.46e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—PIK3CA—salivary gland cancer	1.01e-05	5.45e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—EP300—salivary gland cancer	9.77e-06	5.28e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—EP300—salivary gland cancer	9.77e-06	5.28e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TP53—salivary gland cancer	9.77e-06	5.28e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	9.63e-06	5.2e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MAP2K2—salivary gland cancer	9.6e-06	5.19e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—PIK3CA—salivary gland cancer	9.54e-06	5.15e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NUP62—salivary gland cancer	9.52e-06	5.14e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—VCAN—salivary gland cancer	9.44e-06	5.1e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—HRAS—salivary gland cancer	9.34e-06	5.05e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—PIK3CA—salivary gland cancer	9.16e-06	4.95e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	9.09e-06	4.91e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MAP2K2—salivary gland cancer	8.96e-06	4.84e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	8.94e-06	4.83e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—HRAS—salivary gland cancer	8.83e-06	4.77e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	8.52e-06	4.6e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HRAS—salivary gland cancer	8.48e-06	4.58e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	8.43e-06	4.56e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	8.29e-06	4.48e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—PIK3CA—salivary gland cancer	8.08e-06	4.37e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—PIK3CA—salivary gland cancer	7.99e-06	4.32e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	7.94e-06	4.29e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PTEN—salivary gland cancer	7.88e-06	4.26e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NOTCH1—salivary gland cancer	7.87e-06	4.25e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—salivary gland cancer	7.82e-06	4.22e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—EP300—salivary gland cancer	7.57e-06	4.09e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EP300—salivary gland cancer	7.51e-06	4.06e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HRAS—salivary gland cancer	7.48e-06	4.04e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HRAS—salivary gland cancer	7.39e-06	3.99e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NOTCH1—salivary gland cancer	7.34e-06	3.96e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	7.27e-06	3.93e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	7.23e-06	3.9e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PIK3CA—salivary gland cancer	7.23e-06	3.9e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PIK3CA—salivary gland cancer	7.23e-06	3.9e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CREBBP—salivary gland cancer	7.13e-06	3.85e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CREBBP—salivary gland cancer	7.02e-06	3.79e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—salivary gland cancer	6.99e-06	3.78e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—salivary gland cancer	6.99e-06	3.78e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	6.93e-06	3.75e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	6.89e-06	3.72e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HRAS—salivary gland cancer	6.69e-06	3.61e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HRAS—salivary gland cancer	6.69e-06	3.61e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CREBBP—salivary gland cancer	6.65e-06	3.59e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	6.49e-06	3.51e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	6.3e-06	3.4e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	6.19e-06	3.34e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	5.92e-06	3.2e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	5.64e-06	3.05e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—PIK3CA—salivary gland cancer	5.6e-06	3.03e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CREBBP—salivary gland cancer	5.57e-06	3.01e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PIK3CA—salivary gland cancer	5.56e-06	3e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—salivary gland cancer	5.42e-06	2.93e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCND1—salivary gland cancer	5.28e-06	2.85e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—HRAS—salivary gland cancer	5.18e-06	2.8e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HRAS—salivary gland cancer	5.14e-06	2.78e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	5.13e-06	2.77e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	5.1e-06	2.75e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTEN—salivary gland cancer	5.09e-06	2.75e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTEN—salivary gland cancer	5.01e-06	2.71e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EP300—salivary gland cancer	4.86e-06	2.62e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—EP300—salivary gland cancer	4.78e-06	2.58e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PTEN—salivary gland cancer	4.75e-06	2.57e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	4.58e-06	2.47e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CREBBP—salivary gland cancer	4.53e-06	2.45e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EP300—salivary gland cancer	4.53e-06	2.45e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CREBBP—salivary gland cancer	4.51e-06	2.44e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	4.17e-06	2.25e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CREBBP—salivary gland cancer	4.05e-06	2.19e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PTEN—salivary gland cancer	3.98e-06	2.15e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CREBBP—salivary gland cancer	3.95e-06	2.13e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—EP300—salivary gland cancer	3.8e-06	2.05e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CREBBP—salivary gland cancer	3.69e-06	1.99e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CA—salivary gland cancer	3.59e-06	1.94e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CA—salivary gland cancer	3.54e-06	1.91e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—salivary gland cancer	3.48e-06	1.88e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CA—salivary gland cancer	3.35e-06	1.81e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HRAS—salivary gland cancer	3.32e-06	1.8e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTEN—salivary gland cancer	3.24e-06	1.75e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTEN—salivary gland cancer	3.22e-06	1.74e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HRAS—salivary gland cancer	3.1e-06	1.68e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—EP300—salivary gland cancer	3.09e-06	1.67e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—EP300—salivary gland cancer	3.07e-06	1.66e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTEN—salivary gland cancer	2.89e-06	1.56e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTEN—salivary gland cancer	2.82e-06	1.52e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CA—salivary gland cancer	2.81e-06	1.52e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—EP300—salivary gland cancer	2.76e-06	1.49e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—EP300—salivary gland cancer	2.69e-06	1.45e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTEN—salivary gland cancer	2.64e-06	1.42e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—EP300—salivary gland cancer	2.51e-06	1.36e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CA—salivary gland cancer	2.28e-06	1.23e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CA—salivary gland cancer	2.27e-06	1.23e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CA—salivary gland cancer	2.04e-06	1.1e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CA—salivary gland cancer	1.99e-06	1.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CA—salivary gland cancer	1.86e-06	1e-05	CbGpPWpGaD
